CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Lobe Sciences Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Lobe Sciences Ltd
Suite 1400-1199 West Hastings Street
Phone: (604) 834-9499p:604 834-9499 VANCOUVER, BC  V6E 3T2  Canada Ticker: LOBELOBE

Business Summary
Lobe Sciences Ltd. is a Canada-based biopharmaceutical company focused on developing patient-friendly, practical psychedelic medicines. The Company, through collaborations with partners, is engaged in drug research and development using sub-hallucinatory doses of proprietary compounds to treat Orphan diseases. Its new chemical entities, L-130 and L-131, are being developed to address unmet medical needs such as Chronic Cluster Headaches and other Orphan diseases. In addition, the Company is commercializing Altemia, for the treatment of patients diagnosed with Sickle Cell Disease. Its subsidiaries include Eleusian Biosciences Corp., Lobe Sciences Australia Pty Ltd. and Altemia & Company, LLC.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
11/30/20238/31/2023Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Executive Chairman of the Board Jonathan R.Gilbert 50 12/14/2020 7/27/2020
Chief Executive Officer, Corporate Secretary, Director Philip J.Young 1/15/2021 1/15/2021
Chief Financial Officer BrianZasitko 1/1/2020 1/1/2020
Chief Operating Officer, Director BaxterPhillips 40 6/7/2023 10/1/2022
Independent Director MichaelPetter 1/8/2021 1/8/2021

Business Names
Business Name
BET
BET.H
GSTR
LOBE

General Information
Outstanding Shares: 79,136,172 (As of 11/30/2023)
Stock Exchange: CNQ
Fax Number: (604) 628-1249


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, March 18, 2024